Information on this page is intended for UK healthcare professionals only and may contain promotional material
This page is only intended for UK healthcare professionals. Adverse event reporting can be found near the bottom of the page.
Tillotts Products may be discussed in the content of these modules where prescribing information will be available.
Modules
Modules include
Introduction to CDI and treatment guidelines
This module covers the symptoms and complications of C. difficile infection, how the infection is transmitted, the risk factors associated with getting the infection and its treatment and prevention.
30 minutes
Introduction to CDI and treatment guidelines
This module covers the symptoms and complications of C. difficile infection, how the infection is transmitted, the risk factors associated with getting the infection and its treatment and prevention.
30 minutes
Antimicrobial Stewardship
This module aims to provide you with an introduction to Antimicrobial Stewardship (AMS) with a focus on AMS principles. This module was co-developed with a practicing pharmacist, Dr Stephen Hughes, bringing together clinical insights and current evidence and guidelines and the realities of day-to-day decision making.
60 minutes
Antimicrobial Stewardship
This module aims to provide you with an introduction to Antimicrobial Stewardship (AMS) with a focus on AMS principles. This module was co-developed with a practicing pharmacist, Dr Stephen Hughes, bringing together clinical insights and current evidence and guidelines and the realities of day-to-day decision making.
60 minutes
Managing CDI in Vulnerable Patients
This module consists of two recorded Tillotts symposia, offering practical, clinician-led insights into the management of CDI in high-risk patients. Through recorded sessions, expert healthcare professionals share real-world strategies for recognising, treating, and supporting patients with conditions such as inflammatory bowel disease (IBD) and chronic kidney disease (CKD).
60 minutes
Managing CDI in Vulnerable Patients
This module consists of two recorded Tillotts symposia, offering practical, clinician-led insights into the management of CDI in high-risk patients. Through recorded sessions, expert healthcare professionals share real-world strategies for recognising, treating, and supporting patients with conditions such as inflammatory bowel disease (IBD) and chronic kidney disease (CKD).
60 minutes
Introduction to CDI and treatment guidelines
This module covers the symptoms and complications of C. difficile infection, how the infection is transmitted, the risk factors associated with getting the infection and its treatment and prevention.
30 minutes
Introduction to CDI and treatment guidelines
This module covers the symptoms and complications of C. difficile infection, how the infection is transmitted, the risk factors associated with getting the infection and its treatment and prevention.
30 minutes
CDI testing and diagnosis
This module covers the signs and symptoms of CDI, differential diagnosis, the two step diagnostic algorithm as well as an overview of the laboratory tests for CDI diagnosis.
30 Minutes
CDI testing and diagnosis
This module covers the signs and symptoms of CDI, differential diagnosis, the two step diagnostic algorithm as well as an overview of the laboratory tests for CDI diagnosis.
30 Minutes
Assessment of acute diarrhoea: NICE guidelines
The management of acute diarrhoea in adults including its assessment, how it should be investigated in primary care and finally information on sending a stool sample.
20 minutes
Assessment of acute diarrhoea: NICE guidelines
The management of acute diarrhoea in adults including its assessment, how it should be investigated in primary care and finally information on sending a stool sample.
20 minutes
Patient and carer stories of C.diff
This module highlights the human burden of CDI and the psychological impact it has on patients diagnosed with the infection.
18 minutes
Patient and carer stories of C.diff
This module highlights the human burden of CDI and the psychological impact it has on patients diagnosed with the infection.
18 minutes
C.diff Decoded: Insights from experts
This module provides a brief summary of four clinical papers presented by one of their authors, Dr Simon Goldenberg, Dr Kerrie Davies and Dr Tim Planche.
30 minutes
C.diff Decoded: Insights from experts
This module provides a brief summary of four clinical papers presented by one of their authors, Dr Simon Goldenberg, Dr Kerrie Davies and Dr Tim Planche.
30 minutes
Antibiotics for CDI
This module gives a brief overview of antimicrobials for the treatment of CDI.
30 minutes
Antibiotics for CDI
This module gives a brief overview of antimicrobials for the treatment of CDI.
30 minutes
Human burden of CDI
The impact of CDI on health-related quality of life, the impact on patients work-life, the impact of recurrent CDI, and long-lasting impact on QoL that CDI can cause.
14 minutes
Human burden of CDI
The impact of CDI on health-related quality of life, the impact on patients work-life, the impact of recurrent CDI, and long-lasting impact on QoL that CDI can cause.
14 minutes
CDI epidemiology
A brief overview of C.difficile infection epidemiology, the incidence of CDI, the epidemiology of community-acquired CDI, CDI risk factors, antibiotic-associated diarrhoea and CDI, and COVID-19.
30 minutes
CDI epidemiology
A brief overview of C.difficile infection epidemiology, the incidence of CDI, the epidemiology of community-acquired CDI, CDI risk factors, antibiotic-associated diarrhoea and CDI, and COVID-19.
30 minutes
Genetic Characterisation of C.diff
C. difficile genetics, molecular characterisation and surveillance of ribotypes and strain types, and prevalent ribotypes and strain types in the UK and Ireland.
30 minutes
Genetic Characterisation of C.diff
C. difficile genetics, molecular characterisation and surveillance of ribotypes and strain types, and prevalent ribotypes and strain types in the UK and Ireland.
30 minutes
CDI Webinar Series
This module is divided into various training videos which cover everyday clinical practice and the latest topics in Clostridioides difficile infection featuring guest speakers.
60 minutes each
CDI Webinar Series
This module is divided into various training videos which cover everyday clinical practice and the latest topics in Clostridioides difficile infection featuring guest speakers.
60 minutes each
Revisit the Tillotts CDI Webinars
These webinars cover everyday clinical practice and the latest topics in Clostridioides difficile infection (approx time for all of them 1 hour)
Report a side effect
Adverse events should be reported. Reporting forms and information can be found at:
Adverse events should also be reported to Tillotts Pharma UK Ltd on:
T. 01522 813500
PU-03395 | July 2026
The information on the following pages is intended only for UK resident patients and have been prescribed Octasa, Entocort Enema or budesonide CR 3 mg Capsules
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
Adverse events should also be reported to Tillotts Pharma UK Ltd on 01522813500 or uksafety@tillotts.com
You are about to leave tillotts.co.uk for an external website. Tillotts is not responsible for the content of other websites.
